Confocal laser endomicroscopy predicts response in patients with acute inflammatory bowel disease undergoing anti-integrin therapy with Vedolizumab.

被引:0
|
作者
Ellrichmann, Mark [1 ]
Bethge, Johannes [1 ]
Aust, Golo [1 ]
Arlt, Alexander [1 ]
Brandt, Berenice [1 ]
Zeissig, Sebastian [1 ,2 ,3 ]
Nikolaus, Susanna [1 ]
Aden, Konrad [1 ]
Schreiber, Stefan [1 ]
机构
[1] Univ Hosp Schleswig Holstein, Dept Med 1, Campus Kiel, Kiel, Germany
[2] Tech Univ Dresden, Dept Med 1, Dresden, Germany
[3] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany
关键词
D O I
10.1016/j.gie.2016.03.113
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
574
引用
收藏
页码:AB154 / AB154
页数:1
相关论文
共 50 条
  • [21] Confocal laser endomicroscopy in inflammatory bowel disease: achieving new depths in mucosal healing
    Chapman, Christopher G.
    Konda, Vani J. A.
    GASTROINTESTINAL ENDOSCOPY, 2016, 83 (04) : 792 - 794
  • [22] Hepcidin and Iron Status in Patients With Inflammatory Bowel Disease Undergoing Induction Therapy With Vedolizumab or Infliximab
    Loveikyte, Roberta
    Bourgonje, Arno R.
    van der Reijden, Johannes J.
    Bulthuis, Marian L. C.
    Hawinkels, Lukas J. A. C.
    Visschedijk, Marijn C.
    Festen, Eleonora A. M.
    van Dullemen, Hendrik M.
    Weersma, Rinse K.
    van Goor, Harry
    van der Meulen-de Jong, Andrea E.
    Dijkstra, Gerard
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (08) : 1272 - 1284
  • [23] Anti-integrin drugs in clinical trials for inflammatory bowel disease (IBD): insights into promising agents
    Solitano, Virginia
    Parigi, Tommaso Lorenzo
    Ragaini, Elisa
    Danese, Silvio
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (10) : 1037 - 1046
  • [24] MIN score predicts primary response to infliximab/adalimumab and vedolizumab therapy in patients with inflammatory bowel diseases
    Shi, Yuan
    He, Wei
    Zhong, Ming
    Yu, Minhao
    GENOMICS, 2021, 113 (04) : 1988 - 1998
  • [25] The Predictive Value of Probe-Based Confocal Laser Endomicroscopy (pCLE) Findings in Pediatric Inflammatory Bowel Disease Patients
    Shavrov, Anton
    Kharitonova, Anastasia
    Claggett, Brian
    Shavrov, Andrey
    Liu, Julia J.
    GASTROENTEROLOGY, 2014, 146 (05) : S214 - S214
  • [26] Integrin α4β7 expression preceding and saturation during vedolizumab therapy correlate with treatment response in inflammatory bowel disease
    Boden, Elisa K.
    Shows, Donna
    Chiorean, Michael V.
    Lord, James D.
    GASTROENTEROLOGY, 2017, 152 (05) : S39 - S39
  • [27] Increased Epithelial Gap Density as Measured by Probe-Based Confocal Laser Endomicroscopy Predicts the Need for Future Hospitalization in Patients With Inflammatory Bowel Disease (IBD)
    Turcotte, Jean-Francois
    Wong, Karen
    Mah, Stephanie J.
    Dieleman, Levinus A.
    Fedorak, Richard N.
    Wine, Eytan
    Kroeker, Karen I.
    Liu, Julia J.
    GASTROENTEROLOGY, 2012, 142 (05) : S6 - S7
  • [28] Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease
    Amiot, Aurelien
    Grimaud, Jean-Charles
    Peyrin-Biroulet, Laurent
    Filippi, Jerome
    Pariente, Benjamin
    Roblin, Xavier
    Buisson, Anthony
    Stefanescu, Carmen
    Trang-Poisson, Caroline
    Altwegg, Romain
    Marteau, Philippe
    Vaysse, Thibaud
    Bourrier, Anne
    Nancey, Stephane
    Laharie, David
    Allez, Matthieu
    Savoye, Guillaume
    Moreau, Jacques
    Gagniere, Charlotte
    Vuitton, Lucine
    Viennot, Stephanie
    Aubourg, Alexandre
    Pelletier, Anne-Laure
    Bouguen, Guillaume
    Abitbol, Vered
    Bouhnik, Yoram
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (11) : 1593 - +
  • [29] In Vivo Molecular Imaging Using Fluorescent Anti-TNF Antibodies and Confocal Laser Endomicroscopy Predicts Response to Anti-TNF Therapy in Crohn's Disease
    Atreya, Raja
    Neumann, Helmut
    Neufert, Clemens
    Waldner, Maximilian J.
    Zopf, Yurdaguel
    Willma, Marcus
    App, Christine
    Muenster, Tino
    Kessler, Hermann
    Maas, Stefanie
    Gebhardt, Bernd
    Heimke-Brinck, Ralph
    Reuter, Eva
    Doerje, Frank
    Rau, Tilman T.
    Wang, Thomas D.
    Kiesslich, Ralf
    Vieth, Michael
    Hannappel, Ewald
    Neurath, Markus F.
    GASTROENTEROLOGY, 2013, 144 (05) : S85 - S86
  • [30] RISK OF POSTOPERATIVE COMPLICATIONS AMONG INFLAMMATORY BOWEL DISEASE PATIENTS TREATED PREOPERATIVELY WITH ANTI-INTEGRIN AND ANTI-TUMOR NECROSIS FACTOR AGENTS
    Yamada, Akihiro
    Komaki, Yuga
    Patel, Nayan
    Komaki, Fukiko
    Pekow, Joel R.
    Dalal, Sushila
    Cohen, Russell D.
    Cannon, Lisa
    Umanskiy, Konstantin
    Smith, Radhika
    Hurst, Roger
    Hyman, Neil
    Rubin, David T.
    Sakuraba, Atsushi
    GASTROENTEROLOGY, 2017, 152 (05) : S574 - S574